FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to pyridine derivatives of formula
wherein A, R1, R2, R3, R4, R5 and R6 are presented in the description, preparing and using them as pharmaceutically active compounds as immunomodulatory agents.
EFFECT: preparing the pharmaceutical composition showing agonist activity with respect to S1P1/EDG1 receptor and using it for prevention and treatment diseases or disorders associated with activated immune system.
20 cl, 244 ex, 2 tbl
Title | Year | Author | Number |
---|---|---|---|
NOVEL THIOPHENE DERIVATIVES AS S1P1/EDG1 RECEPTOR AGONISTS | 2007 |
|
RU2437877C2 |
PYRIDIN-3-YL DERIVATIVES AS IMMUNOMODULATORY AGENTS | 2007 |
|
RU2454413C2 |
NEW THIOPHENE DERIVATIVES AS S1P1/EDG1 RECEPTOR AGONISTS | 2007 |
|
RU2442783C2 |
PYRIDIN-2-YL DERIVATIVES AS IMMUNOMODULATORY AGENTS | 2009 |
|
RU2494099C2 |
HYDROGENATED DERIVATIVES OF BENZO[C]THIOPHENE AS IMMUNOMODULATORS | 2006 |
|
RU2412179C2 |
PHENYL DERIVATIVES AND THEIR APPLICATION AS IMMUNOMODULATORS | 2007 |
|
RU2442780C2 |
PYRIMIDIN-4-YL DERIVATIVES | 2010 |
|
RU2547098C2 |
2-METHOXY-PYRIDIN-4-YL DERIVATIVES | 2012 |
|
RU2588141C2 |
CARBOXYLIC ACID DERIVATIVES CONTAINING 2,5-SUBSTITUTED OXAZOLOPYRIMIDINE RING | 2011 |
|
RU2564018C2 |
BISPHENOL DERIVATIVES AND THEIR USE AS ACTIVITY MODULATORS OF ANDROGEN RECEPTOR | 2017 |
|
RU2767257C2 |
Authors
Dates
2012-04-10—Published
2007-09-06—Filed